Equities research analysts expect Envision Healthcare Co. (NYSE:EVHC) to report earnings of $0.71 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Envision Healthcare’s earnings, with the highest EPS estimate coming in at $0.84 and the lowest estimate coming in at $0.56. Envision Healthcare posted earnings of $0.77 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 7.8%. The firm is expected to issue its next quarterly earnings results on Tuesday, May 1st.
According to Zacks, analysts expect that Envision Healthcare will report full year earnings of $3.52 per share for the current fiscal year, with EPS estimates ranging from $2.98 to $3.86. For the next year, analysts forecast that the company will post earnings of $3.90 per share, with EPS estimates ranging from $3.49 to $4.56. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.59 EPS for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.14. Envision Healthcare had a negative net margin of 2.52% and a positive return on equity of 4.62%. The business had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the company earned $1.15 EPS. The firm’s quarterly revenue was up 68.0% on a year-over-year basis.
Several institutional investors have recently bought and sold shares of EVHC. OZ Management LP acquired a new position in shares of Envision Healthcare during the 3rd quarter worth about $131,987,000. Maverick Capital Ltd. boosted its stake in shares of Envision Healthcare by 30.7% during the 4th quarter. Maverick Capital Ltd. now owns 10,002,182 shares of the company’s stock worth $345,675,000 after buying an additional 2,349,648 shares during the last quarter. Guggenheim Capital LLC boosted its stake in shares of Envision Healthcare by 140.4% during the 4th quarter. Guggenheim Capital LLC now owns 1,979,973 shares of the company’s stock worth $68,429,000 after buying an additional 1,156,381 shares during the last quarter. Sapience Investments LLC boosted its stake in shares of Envision Healthcare by 152.0% during the 4th quarter. Sapience Investments LLC now owns 1,127,610 shares of the company’s stock worth $38,970,000 after buying an additional 680,220 shares during the last quarter. Finally, Douglas Lane & Associates LLC boosted its stake in shares of Envision Healthcare by 512.8% during the 4th quarter. Douglas Lane & Associates LLC now owns 672,252 shares of the company’s stock worth $23,233,000 after buying an additional 562,554 shares during the last quarter.
Envision Healthcare (NYSE:EVHC) traded up $0.39 on Wednesday, hitting $40.44. 1,224,016 shares of the company were exchanged, compared to its average volume of 2,424,993. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40. Envision Healthcare has a 1-year low of $23.77 and a 1-year high of $69.21. The company has a market cap of $4,840.00, a PE ratio of 18.71, a P/E/G ratio of 0.98 and a beta of 0.48.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2018/03/05/1807136.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.